Growth, characterisation and seroprevalence of an encephalitozoon SP from an AIDS patient with disseminated microsporidiosis. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Growth, characterisation and seroprevalence of an encephalitozoon SP from an AIDS patient with disseminated microsporidiosis.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:31 (abstract no. TC10). Unique Identifier : AIDSLINE ASHM5/94348955
Doultree JC; Ryan N; Druce J; Maerz A; Crowe S; Marshall J; Fairfield Hospital, Victoria.

Abstract: Although microsporidia (MS) are important opportunistic pathogens in Acquired Immunodeficiency Syndrome (AIDS) patients, the in vitro characteristics and seroprevalence of many human species are poorly understood. Light microscopy and electron microscopy confirmed the presence of Encephalitozoon sp spores from a nasopharyngeal aspirate (NPA), urine and faeces from an AIDS patient. MS from NPA inoculated into Human Embryonic Lung cells and macrophages were found to replicate successfully. Seroprevalence studies indicated a high incidence of antibody to the parasite in both Human Immunodeficiency Virus (HIV) positive and HIV negative groups.
Keywords: Animal Antibodies, Protozoan/ANALYSIS AIDS-Related Opportunistic Infections/*DIAGNOSIS/EPIDEMIOLOGY/ IMMUNOLOGY Cross-Sectional Studies Encephalitozoonosis/*DIAGNOSIS/EPIDEMIOLOGY/IMMUNOLOGY Human Microspora/GROWTH & DEVELOPMENT/IMMUNOLOGY Microspora Infections/*DIAGNOSIS/EPIDEMIOLOGY/IMMUNOLOGY Victoria/EPIDEMIOLOGY ABSTRACTKWDanimalantibodies,protozoan/analysisaids-relatedopportunisticinfections/KWDdiagnosis/epidemiology/immunologycross-sectionalstudiesencephalitozoonosis/KWDdiagnosis/epidemiology/immunologyhumanmicrospora/growth&development/immunologymicrosporainfections/KWDdiagnosis/epidemiology/immunologyvictoria/epidemiologyabstract
941230
M94C4272

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .